Research from the Institute of Cancer Research in London shows a promising new DNA analysis method that predicts bowel cancer risk with over 90% accuracy in high-risk patients, particularly those with inflammatory bowel disease (IBD). Currently, 500,000 people in the UK manage IBD, which includes Crohn's and ulcerative colitis. The ability to predict bowel cancer risk within five years could lead to developing a simple blood test to identify patients most at risk, potentially changing cancer screening processes and improving patient outcomes.
The researchers found that DNA changes in pre-cancerous cells, analyzed by an algorithm, were over 90% accurate in predicting who would develop bowel cancer in five years.
Research like this will save lives. It gives me comfort to know that there are scientists working right now so that no-one has to experience the same situation Fariba was in.
For those with ulcerative colitis or Crohn's disease showing pre-cancer signs, tough decisions about monitoring or treatment must be made to mitigate bowel cancer risks.
About 500,000 people in the UK live with inflammatory bowel disease, highlighting the need for efficient screening methods to prevent potential bowel cancer cases.
Collection
[
|
...
]